Skip to main content
Top
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Acute Pancreatitis | Research

Clinical characteristics and short-term outcomes of acute pancreatitis among patients with COVID-19

Authors: Jinchang Zhang, De Luo, Maoji Kang, Bo Li, Song Su

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Objective

The existing literature on the combination of acute pancreatitis (AP) and COVID-19 is scarce. The objective of our study is to compare the clinical outcomes and occurrence of long COVID syndrome in AP patients with and without COVID-19, while investigating the potential impact of COVID-19 on the severity, mortality rate, and long COVID syndrome in these patients.

Methods

This retrospective, observational study was conducted at a single center. It included patients aged 18 years and above who were diagnosed with AP during the pandemic. Patients were categorized into two groups based on the results of RT-qPCR testing: the SARS-CoV-2-positive group and the SARS-CoV-2-negative group. The study aimed to compare the severity of AP, mortality rate, and occurrence of long COVID syndrome between these two groups.

Result

A retrospective review was conducted on 122 patients diagnosed with acute pancreatitis between December 1, 2022, and January 31, 2023. Out of these patients, 100 were included in the study. The analysis revealed no significant differences in mortality rate, severity, and sequelae between AP patients with COVID-19 and those without COVID-19 (p > 0.005). However, a statistically significant difference was observed in the occurrence of long COVID syndrome, specifically in the presence of cough (p = 0.04).

Conclusion

This study demonstrates that the presence of COVID-19 in patients with pancreatitis does not lead to an increase in the mortality and severity rate of pancreatitis.
Literature
1.
go back to reference Boxhoorn L, Voermans RP, Bouwense SA, Bruno MJ, Verdonk RC, Boermeester MA, et al. Acute pancreatitis. Lancet. 2020;396(10252):726–34.CrossRefPubMed Boxhoorn L, Voermans RP, Bouwense SA, Bruno MJ, Verdonk RC, Boermeester MA, et al. Acute pancreatitis. Lancet. 2020;396(10252):726–34.CrossRefPubMed
2.
go back to reference Schepers NJ, Bakker OJ, Besselink MG, Ahmed Ali U, Bollen TL, Gooszen HG, et al. Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis. Gut. 2019;68(6):1044–51.CrossRefPubMed Schepers NJ, Bakker OJ, Besselink MG, Ahmed Ali U, Bollen TL, Gooszen HG, et al. Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis. Gut. 2019;68(6):1044–51.CrossRefPubMed
3.
go back to reference He W, Chen P, Lei Y, Xia L, Liu P, Zhu Y, et al. Randomized controlled trial: neostigmine for intra-abdominal hypertension in acute pancreatitis. Crit Care. 2022;26(1):52.CrossRefPubMedPubMedCentral He W, Chen P, Lei Y, Xia L, Liu P, Zhu Y, et al. Randomized controlled trial: neostigmine for intra-abdominal hypertension in acute pancreatitis. Crit Care. 2022;26(1):52.CrossRefPubMedPubMedCentral
12.
go back to reference Hromić-Jahjefendić A, Barh D, Uversky V, Aljabali AA, Tambuwala MM, Alzahrani KJ, et al. Can COVID-19 vaccines induce premature non-communicable diseases: where are we heading to? Vaccines (Basel). 2023;11(2):208.CrossRefPubMed Hromić-Jahjefendić A, Barh D, Uversky V, Aljabali AA, Tambuwala MM, Alzahrani KJ, et al. Can COVID-19 vaccines induce premature non-communicable diseases: where are we heading to? Vaccines (Basel). 2023;11(2):208.CrossRefPubMed
16.
go back to reference Ma E, Ai J, Zhang Y, Zheng J, Gao X, Xu J, et al. Omicron infections profile and vaccination status among 1881 liver transplant recipients: a multi-centre retrospective cohort. Emerg Microbes Infect. 2022;11(1):2636–44.CrossRefPubMedPubMedCentral Ma E, Ai J, Zhang Y, Zheng J, Gao X, Xu J, et al. Omicron infections profile and vaccination status among 1881 liver transplant recipients: a multi-centre retrospective cohort. Emerg Microbes Infect. 2022;11(1):2636–44.CrossRefPubMedPubMedCentral
17.
go back to reference Yang F, Huang Y, Li T, Fu Y, Sun C, Xu Y, et al. Prevalence and outcomes of acute pancreatitis in COVID-19: a meta-analysis. Gut. 2022;71(7):1451–3.CrossRefPubMed Yang F, Huang Y, Li T, Fu Y, Sun C, Xu Y, et al. Prevalence and outcomes of acute pancreatitis in COVID-19: a meta-analysis. Gut. 2022;71(7):1451–3.CrossRefPubMed
19.
go back to reference Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022;22(9):1293–302.CrossRefPubMedPubMedCentral Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022;22(9):1293–302.CrossRefPubMedPubMedCentral
20.
go back to reference Rai P, Kumar BK, Deekshit VK, Karunasagar I, Karunasagar I. Detection technologies and recent developments in the diagnosis of COVID-19 infection. Appl Microbiol Biotechnol. 2021;105(2):441–55.CrossRefPubMedPubMedCentral Rai P, Kumar BK, Deekshit VK, Karunasagar I, Karunasagar I. Detection technologies and recent developments in the diagnosis of COVID-19 infection. Appl Microbiol Biotechnol. 2021;105(2):441–55.CrossRefPubMedPubMedCentral
22.
go back to reference Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–11.CrossRefPubMed Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–11.CrossRefPubMed
23.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed
25.
go back to reference Wu BU, Johannes RS, Sun X, Tabak Y, Conwell DL, Banks PA. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut. 2008;57(12):1698–703.CrossRefPubMed Wu BU, Johannes RS, Sun X, Tabak Y, Conwell DL, Banks PA. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut. 2008;57(12):1698–703.CrossRefPubMed
26.
go back to reference Singh VK, Wu BU, Bollen TL, Repas K, Maurer R, Johannes RS, et al. A prospective evaluation of the bedside index for severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis. Am J Gastroenterol. 2009;104(4):966–71.CrossRefPubMed Singh VK, Wu BU, Bollen TL, Repas K, Maurer R, Johannes RS, et al. A prospective evaluation of the bedside index for severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis. Am J Gastroenterol. 2009;104(4):966–71.CrossRefPubMed
27.
go back to reference Cheng T, Han TY, Liu BF, Pan P, Lai Q, Yu H, et al. Use of modified balthazar grades for the early prediction of acute pancreatitis severity in the emergency department. Int J Gen Med. 2022;15:1111–9.CrossRefPubMedPubMedCentral Cheng T, Han TY, Liu BF, Pan P, Lai Q, Yu H, et al. Use of modified balthazar grades for the early prediction of acute pancreatitis severity in the emergency department. Int J Gen Med. 2022;15:1111–9.CrossRefPubMedPubMedCentral
28.
go back to reference Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23(10):1638–52.CrossRefPubMed Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23(10):1638–52.CrossRefPubMed
29.
go back to reference Lai FTT, Yan VKC, Ye X, Ma T, Qin X, Chui CSL, et al. Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19-related deaths among people with multimorbidity: a cohort study. CMAJ. 2023;195(4):E143–52.CrossRefPubMedPubMedCentral Lai FTT, Yan VKC, Ye X, Ma T, Qin X, Chui CSL, et al. Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19-related deaths among people with multimorbidity: a cohort study. CMAJ. 2023;195(4):E143–52.CrossRefPubMedPubMedCentral
30.
go back to reference Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, et al. A global database of COVID-19 vaccinations. Nat Hum Behav. 2021;5(7):947–53.CrossRefPubMed Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, et al. A global database of COVID-19 vaccinations. Nat Hum Behav. 2021;5(7):947–53.CrossRefPubMed
35.
go back to reference Zheng L, Zhang L, Zheng Y, An J, Wen G, Jin H, et al. Digestive system infection by SARS-CoV-2: entry mechanism, clinical symptoms and expression of major receptors (Review). Int J Mol Med. 2023;51(3):1–11.CrossRef Zheng L, Zhang L, Zheng Y, An J, Wen G, Jin H, et al. Digestive system infection by SARS-CoV-2: entry mechanism, clinical symptoms and expression of major receptors (Review). Int J Mol Med. 2023;51(3):1–11.CrossRef
40.
go back to reference Howe S, Szanyi J, Blakely T. The health impact of long COVID during the 2021–2022 Omicron wave in Australia: a quantitative burden of disease study. Int J Epidemiol. 2023;52(3):677–89.CrossRefPubMedPubMedCentral Howe S, Szanyi J, Blakely T. The health impact of long COVID during the 2021–2022 Omicron wave in Australia: a quantitative burden of disease study. Int J Epidemiol. 2023;52(3):677–89.CrossRefPubMedPubMedCentral
41.
go back to reference Richard SA, Pollett SD, Fries AC, Berjohn CM, Maves RC, Lalani T, et al. Persistent COVID-19 symptoms at 6 months after onset and the role of vaccination before or after SARS-CoV-2 infection. JAMA Netw Open. 2023;6(1): e2251360.CrossRefPubMedPubMedCentral Richard SA, Pollett SD, Fries AC, Berjohn CM, Maves RC, Lalani T, et al. Persistent COVID-19 symptoms at 6 months after onset and the role of vaccination before or after SARS-CoV-2 infection. JAMA Netw Open. 2023;6(1): e2251360.CrossRefPubMedPubMedCentral
Metadata
Title
Clinical characteristics and short-term outcomes of acute pancreatitis among patients with COVID-19
Authors
Jinchang Zhang
De Luo
Maoji Kang
Bo Li
Song Su
Publication date
01-12-2023
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01252-x

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue